What does Samsung Epis Holdings do?

Samsung Epis Holdings (0126Z0.KS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 0126Z0.KS's market cap?

Samsung Epis Holdings (0126Z0.KS) has a market capitalization of approximately $9.58 trillion, as of July 22, 2026, based on the most recent share price and shares outstanding.

Does 0126Z0.KS pay a dividend?

No — Samsung Epis Holdings (0126Z0.KS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

0126Z0.KS (Samsung Epis Holdings) is a recent IPO.

It began trading on November 24, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

0126Z0.KS

Samsung Epis Holdings

KSC·Biotechnology · Healthcare

₩385,000₩6,500+1.72%

Market cap₩9.58T·Market closed·Jul 22 2:05 AM UTC

Price Chart

₩385,000+₩6,500.00 (+1.72%)today

−12.09%

Select date range

FromTo

Nov 24, 2025Nov 24, 2025 → Jul 22, 2026· 8 moJul 22, 2026

Key Metrics

0126Z0.KS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)$8,798.50

P/E Ratio (FWD)43.76

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 23

Last Report DateApr 23

Reported vs Estimate₩2.65

Earnings Surprise—

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Price Projection

PRO

A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.

Click below to see what's inside, then upgrade to unlock for 0126Z0.KS and 80,000+ other tickers.

Income Statement Flow

PRO

See exactly how 0126Z0.KS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 0126Z0.KS and 80,000+ other tickers.

About Samsung Epis Holdings

Part of SAMSUNG BIOLOGICS Co., Ltd., Samsung Epis Holdings Co., Ltd. is a South Korean company that provides management and investment services. The company is based in Inchon, South Korea. The CEO of the company is Kyung-Ah Kim.

CEO: Kyung-Ah Kim
Sector: Healthcare
Industry: Biotechnology
Exchange: KSC
Employees: 9
Website: www.samsungepisholdings.com/en

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 0126Z0.KS

What does Samsung Epis Holdings do?: Samsung Epis Holdings (0126Z0.KS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 0126Z0.KS's market cap?: Samsung Epis Holdings (0126Z0.KS) has a market capitalization of approximately $9.58 trillion, as of July 22, 2026, based on the most recent share price and shares outstanding.
Does 0126Z0.KS pay a dividend?: No — Samsung Epis Holdings (0126Z0.KS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.